453 related articles for article (PubMed ID: 27133662)
1. Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis.
Huijbers MG; Niks EH; Klooster R; de Visser M; Kuks JB; Veldink JH; Klarenbeek P; Van Damme P; de Baets MH; van der Maarel SM; van den Berg LH; Verschuuren JJ
Neuromuscul Disord; 2016 Jun; 26(6):350-3. PubMed ID: 27133662
[TBL] [Abstract][Full Text] [Related]
2. Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.
Furuta N; Ishizawa K; Shibata M; Tsukagoshi S; Nagamine S; Makioka K; Fujita Y; Ikeda M; Yoshimura S; Motomura M; Okamoto K; Ikeda Y
Intern Med; 2015; 54(19):2497-501. PubMed ID: 26424311
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
Sanadze AG; Sidnev DV; Karganov MIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
[TBL] [Abstract][Full Text] [Related]
4. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
5. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
6. Anti-MuSK myasthenia gravis with prolonged remission.
Bouwyn JP; Magnier P; Bédat-Millet AL; Ahtoy P; Maltête D; Lefaucheur R
Neuromuscul Disord; 2016 Jul; 26(7):453-4. PubMed ID: 27161384
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
8. Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies.
Verschuuren JJGM; Plomp JJ; Burden SJ; Zhang W; Fillié-Grijpma YE; Stienstra-van Es IE; Niks EH; Losen M; van der Maarel SM; Huijbers MG
Ann N Y Acad Sci; 2018 Feb; 1413(1):111-118. PubMed ID: 29356029
[TBL] [Abstract][Full Text] [Related]
9. Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis.
Bekooij TJS; Gilhuis HJ; Dawson L; Niks EH
J Neuromuscul Dis; 2020; 7(1):47-50. PubMed ID: 31868676
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis patients with anti-MuSK antibodies.
Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
[TBL] [Abstract][Full Text] [Related]
11. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
Reddel SW; Morsch M; Phillips WD
Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity.
Huijbers MG; Vink AF; Niks EH; Westhuis RH; van Zwet EW; de Meel RH; Rojas-García R; Díaz-Manera J; Kuks JB; Klooster R; Straasheijm K; Evoli A; Illa I; van der Maarel SM; Verschuuren JJ
J Neuroimmunol; 2016 Feb; 291():82-8. PubMed ID: 26857500
[TBL] [Abstract][Full Text] [Related]
13. Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: A dysregulation of the adaptive immune system?
Del Mar Amador M; Vandenberghe N; Berhoune N; Camdessanché JP; Gronier S; Delmont E; Desnuelle C; Cintas P; Pittion S; Louis S; Demeret S; Lenglet T; Meininger V; Salachas F; Pradat PF; Bruneteau G
Neuromuscul Disord; 2016 Jun; 26(6):342-6. PubMed ID: 27102004
[TBL] [Abstract][Full Text] [Related]
14. ["Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinase].
Hain B; Hanisch F; Deschauer M
Nervenarzt; 2004 Apr; 75(4):362-7. PubMed ID: 15042294
[TBL] [Abstract][Full Text] [Related]
15. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis.
Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ
Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586
[TBL] [Abstract][Full Text] [Related]
17. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients.
Koneczny I; Stevens JA; De Rosa A; Huda S; Huijbers MG; Saxena A; Maestri M; Lazaridis K; Zisimopoulou P; Tzartos S; Verschuuren J; van der Maarel SM; van Damme P; De Baets MH; Molenaar PC; Vincent A; Ricciardi R; Martinez-Martinez P; Losen M
J Autoimmun; 2017 Feb; 77():104-115. PubMed ID: 27965060
[TBL] [Abstract][Full Text] [Related]
18. [Myasthenia gravis induced by autoantibodies against MuSK].
Shigemoto K; Konishi T; Ohta M
Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
[TBL] [Abstract][Full Text] [Related]
19. An ocular form of myasthenia gravis with a high titer of anti-MuSK antibodies during a long-term follow-up.
Hosaka A; Takuma H; Ohta K; Tamaoka A
Intern Med; 2012; 51(21):3077-9. PubMed ID: 23124154
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis.
Mori S; Shigemoto K
Autoimmun Rev; 2013 Jul; 12(9):912-7. PubMed ID: 23537506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]